UroGen Pharma Ltd. short interest in 2024
In 2024, UroGen Pharma Ltd.'s disclosed short interest ran from 10.99% of shares outstanding on 12 Jan 2024 to 13.81% on 31 Dec 2024, a change of +2.82 percentage points. The year's high was 17.54% on 28 Jun 2024 and its low 10.55% on 31 Jan 2024, averaging 14.33% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.76 days on 12 Jan 2024. Full history: UroGen Pharma Ltd..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 10.99% (12 Jan 2024)
- End of year
- 13.81% (31 Dec 2024)
- Change
- +2.82 pp
- High
- 17.54% (28 Jun 2024)
- Low
- 10.55% (31 Jan 2024)
- Average
- 14.33%
- Highest days to cover
- 22.76 (12 Jan 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 10.99% | 22.76 | |
| 31 Jan 2024 | 10.55% | 10.40 | |
| 15 Feb 2024 | 13.00% | 8.11 | |
| 29 Feb 2024 | 12.75% | 18.98 | |
| 15 Mar 2024 | 13.77% | 14.05 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 13.56% | 7.39 | |
| 15 Apr 2024 | 13.60% | 12.63 | |
| 30 Apr 2024 | 12.27% | 18.98 | |
| 15 May 2024 | 12.37% | 13.40 | 10-Q filed, results (8-K) |
| 31 May 2024 | 14.55% | 21.38 | |
| 14 Jun 2024 | 15.56% | 4.18 | |
| 28 Jun 2024 | 17.54% | 5.44 | |
| 15 Jul 2024 | 16.25% | 12.87 | |
| 31 Jul 2024 | 16.89% | 15.30 | |
| 15 Aug 2024 | 15.40% | 17.02 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 15.30% | 11.10 | |
| 13 Sep 2024 | 15.12% | 15.48 | |
| 30 Sep 2024 | 16.79% | 11.88 | |
| 15 Oct 2024 | 15.41% | 7.86 | |
| 31 Oct 2024 | 15.67% | 10.74 | |
| 15 Nov 2024 | 15.27% | 14.64 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 13.68% | 13.17 | |
| 13 Dec 2024 | 13.78% | 16.92 | |
| 31 Dec 2024 | 13.81% | 12.67 |
See also: UroGen Pharma Ltd.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.